Literature DB >> 7742531

The cloning and characterization of the human transcobalamin II gene.

A Regec1, E V Quadros, O Platica, S P Rothenberg.   

Abstract

Transcobalamin II (TCII) is a plasma protein that binds vitamin B12 (cobalamin; Cbl) and facilitates the cellular uptake of the vitamin by receptor-mediated endocytosis. In genetic disorders that are characterized by congenital deficiency of TCII, intracellular Cbl deficiency occurs, resulting in an early onset of megaloblastic anemia that is sometimes accompanied by a neurologic disorder. To define the genetic basis for TCII deficiency, we have cloned and characterized the human gene that encodes this protein. The gene spans a minimum of 18 kbp and contains nine exons and eight introns, with a polyadenylation signal sequence located 509 bp downstream from the termination codon and a transcription initiation site beginning 158 bp upstream from the ATG translation start site. The 5' flanking DNA does not have a TATA or CCAAT regulatory element, but a 34-nucleotide stretch beginning just upstream of the CAP site contains four tandemly organized 5'-CCCC-3' tetramers. This sequence is a motif for a trans-active transcription factor (ETF) that regulates expression of the epidermal growth factor receptor gene (EGFR), which also lacks TATA and CCAAT regulatory elements. A GC-rich sequence that binds the SP1 protein is located 356 nucleotides upstream from the first of the series of CCCC tetramers. Although this GC sequence is at an unusual location with respect to the CAP site, a 507-bp fragment containing this GC box drives the chloramphenicol acetyltransferase (CAT) reporter gene after transient transfection into NIH 3T3 cells. No CAT activity was observed when a 420-bp fragment lacking this GC box but containing the ETF-binding domains was similarly transfected into this cell line. One consensus and two atypical motifs for the c-myc ligand are located downstream and upstream, respectively, of the GC box, and this could explain the elevated plasma TCII observed in some patients with multiple myeloma, as the c-myc product is overexpressed in some myeloma cells. Restriction endonuclease digestion of genomic DNA from eight normal subjects with Taq I, Hinfl, Msp I, and Bgl I identified three patterns of restriction fragment length polymorphism (RFLP). A number of the exon/intron splice junctions of human TCII, TCI, and IF genes are located in homologous regions of these proteins, providing evidence that these genes have evolved by duplication of an ancestral gene. This characterization of the TCII gene and the RFLP should facilitate the identification of the mutation(s) responsible for the genetic abnormalities of TCII expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742531

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Transcobalamin deficiency caused by compound heterozygosity for two novel mutations in the TCN2 gene: a study of two affected siblings, their brother, and their parents.

Authors:  Peter H Nissen; Maria Nordwall; Elke Hoffmann-Lücke; Boe S Sorensen; Ebba Nexo
Journal:  J Inherit Metab Dis       Date:  2010-07-06       Impact factor: 4.982

2.  Should transcobalamin deficiency be treated aggressively?

Authors:  Manuel Schiff; Hélène Ogier de Baulny; Ghislaine Bard; Vincent Barlogis; Christian Hamel; Stuart J Moat; Sylvie Odent; Graham Shortland; Guy Touati; Stéphane Giraudier
Journal:  J Inherit Metab Dis       Date:  2010-03-30       Impact factor: 4.982

3.  Expanding the Spectrum of Methylmalonic Acid-Induced Pallidal Stroke: First Reported Case of Metabolic Globus Pallidus Stroke in Transcobalamin II Deficiency.

Authors:  Lance Harrington Rodan; Navin Mishra; Ivanna Yau; Andrea Andrade; Komudi Siriwardena; Ingrid Tein
Journal:  JIMD Rep       Date:  2013-02-21

4.  A novel mutation of the transcobalamin II gene in an infant presenting with hemophagocytic lymphohistiocytosis.

Authors:  Selma Unal; Ozlem Tezol; Yesim Oztas
Journal:  Int J Hematol       Date:  2014-02-22       Impact factor: 2.490

Review 5.  Cellular uptake of cobalamin: transcobalamin and the TCblR/CD320 receptor.

Authors:  Edward V Quadros; Jeffrey M Sequeira
Journal:  Biochimie       Date:  2013-02-14       Impact factor: 4.079

6.  The causal roles of vitamin B(12) and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers?

Authors:  Simon M Collin; Chris Metcalfe; Tom M Palmer; Helga Refsum; Sarah J Lewis; George Davey Smith; Angela Cox; Michael Davis; Gemma Marsden; Carole Johnston; J Athene Lane; Jenny L Donovan; David E Neal; Freddie C Hamdy; A David Smith; Richard M Martin
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-28

7.  Transcobalamin (TC) deficiency--potential cause of bone marrow failure in childhood.

Authors:  C Prasad; D S Rosenblatt; K Corley; A E L Cairney; C A Rupar
Journal:  J Inherit Metab Dis       Date:  2008-10-29       Impact factor: 4.982

Review 8.  Advances in the understanding of cobalamin assimilation and metabolism.

Authors:  Edward V Quadros
Journal:  Br J Haematol       Date:  2009-10-12       Impact factor: 6.998

Review 9.  Inborn errors of metabolism underlying primary immunodeficiencies.

Authors:  Nima Parvaneh; Pierre Quartier; Parastoo Rostami; Jean-Laurent Casanova; Pascale de Lonlay
Journal:  J Clin Immunol       Date:  2014-08-01       Impact factor: 8.317

10.  The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin.

Authors:  Edward V Quadros; Yasumi Nakayama; Jeffrey M Sequeira
Journal:  Blood       Date:  2008-09-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.